COF vs EBS
Capital One Financial Corporation (COF) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Capital One Financial Corporation (COF) is a credit services company listed on NYSE.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported COF revenue for 2025-12-31 was $53.43B. Net income was $2.45B. Revenue was up 36.6% from 2024-12-31 to 2025-12-31. COF currently screens at market cap $125.00B and trailing P/E 61.8.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
COF currently screens at market cap $125.00B and trailing P/E 61.8. EBS currently screens at market cap $416.4M.
Not investment advice. Open the COF and EBS stock pages for the full models.
Not investment advice.